Statements (56)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:government_agency
|
| gptkbp:bfsLayer |
5
|
| gptkbp:bfsParent |
gptkb:Emergent_Bio_Solutions
|
| gptkbp:addresses |
biodefense
|
| gptkbp:aims_to |
accelerate medical countermeasures
national health security |
| gptkbp:collaborates_with |
gptkb:private_sector
pharmaceutical companies |
| gptkbp:conducts |
clinical trials
|
| gptkbp:coordinates |
other federal agencies
state and local health departments |
| gptkbp:engages_in |
public-private partnerships
|
| gptkbp:established |
gptkb:2006
|
| gptkbp:facilitates |
regulatory approval
|
| gptkbp:focus_area |
biomedical research
|
| gptkbp:focuses_on |
public health emergencies
infectious disease threats |
| gptkbp:full_name |
gptkb:Biomedical_Advanced_Research_and_Development_Authority
|
| gptkbp:goal |
prepare for public health emergencies
|
| gptkbp:has_departments |
addresses health security challenges.
|
| gptkbp:has_mission |
support the development of medical countermeasures
|
| gptkbp:has_role |
pandemic preparedness
national vaccine strategy |
| gptkbp:headquartered_in |
gptkb:Washington,_D._C.
|
| https://www.w3.org/2000/01/rdf-schema#label |
BARDA
|
| gptkbp:investment |
therapeutics and diagnostics
|
| gptkbp:is_effective_against |
biological threats
|
| gptkbp:is_evaluated_by |
medical products
|
| gptkbp:is_involved_in |
COVID-19 response
emergency medical supply chain research on pandemic influenza vaccine stockpiling |
| gptkbp:is_part_of |
U. S. government's public health strategy
|
| gptkbp:is_tasked_with |
developing countermeasures for chemical threats
|
| gptkbp:key_people |
national preparedness
|
| gptkbp:leadership |
biomedical innovation
|
| gptkbp:manages |
gptkb:Project_Bio_Shield
|
| gptkbp:operates_under |
gptkb:Public_Health_Service_Act
|
| gptkbp:part_of |
gptkb:U._S._Department_of_Health_and_Human_Services
|
| gptkbp:partnerships |
academic institutions
|
| gptkbp:promotes |
innovation in medical technologies
|
| gptkbp:provides |
technical assistance
|
| gptkbp:provides_information_on |
emergency use authorization
|
| gptkbp:receives_funding_from |
gptkb:legislation
research projects advanced research and development |
| gptkbp:responsible_for |
advanced development of vaccines
|
| gptkbp:strategic_importance |
biomedical countermeasures
|
| gptkbp:supports |
vaccine development
antiviral drugs therapeutics for COVID-19 |
| gptkbp:sustainability_initiatives |
rapid response to outbreaks
|
| gptkbp:tactics |
emergency response
|
| gptkbp:works_on |
countermeasures for infectious diseases
diagnostic tests for infectious diseases |
| gptkbp:works_with |
international organizations
|